Abpro Holdings, Inc. (ABPO)
OTCMKTS · Delayed Price · Currency is USD
0.378732
-0.003768 (-0.99%)
At close: Sep 29, 2026
Abpro Holdings Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
2.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 183.00K | 61.00K | 50.00% |
| Dec 31, 2023 | 122.00K | -1.91M | -93.99% |
| Dec 31, 2022 | 2.03M | 1.55M | 322.71% |
| Dec 31, 2021 | 480.00K | -1.72M | -78.19% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CASI Pharmaceuticals | 20.11M |
| International Stem Cell | 9.51M |
| BioAtla | 8.50M |
| Avenue Therapeutics | 1.40M |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| Eastgate Biotech | 137.64K |
| Enzolytics | 46.59K |
Abpro Holdings News
- 6 weeks ago - Abpro Holdings Quarterly report: Q2 2026 - Filings
- 4 months ago - Abpro Holdings Quarterly report: Q1 2026 - Filings
- 5 months ago - Abpro Holdings Annual report: Q4 2025 - Filings
- 8 months ago - Abpro's Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 8 months ago - Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 - GlobeNewsWire
- 9 months ago - Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers - GlobeNewsWire
- 9 months ago - Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives - GlobeNewsWire
- 10 months ago - Abpro Holdings Registration statement: Registration Filing - Filings